L-Methylfolate Augmentation in Depression: A Targeted Strategy for Difficult-to-Treat Patients
Shyam Tailor
When Antidepressants Are Not Enough Despite advances in pharmacotherapy, a substantial proportion of patients with major depressive disorder (MDD) do not achieve full remission with first-line antidepressants. For these individuals, augmentation strategies are essential. While options such as atypical antipsychotics,... The post L-Methylfolate Augmentation in Depression: A Targeted Strategy for Difficult-to-Treat Patients appeared first on Louis A. Faillace, MD, Department of Psychiatry and Beha